Cargando…
The first European consensus on principles of management for achondroplasia
Achondroplasia is the most common type of skeletal dysplasia, caused by a recurrent pathogenic variant in the fibroblast growth factor receptor 3 (FGFR3). The management of achondroplasia is multifaceted, requiring the involvement of multiple specialties across the life course. There are significant...
Autores principales: | Cormier-Daire, Valerie, AlSayed, Moeenaldeen, Ben-Omran, Tawfeg, de Sousa, Sérgio Bernardo, Boero, Silvio, Fredwall, Svein O., Guillen-Navarro, Encarna, Irving, Melita, Lampe, Christian, Maghnie, Mohamad, Mortier, Geert, Peijin, Zagorka, Mohnike, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325831/ https://www.ncbi.nlm.nih.gov/pubmed/34332609 http://dx.doi.org/10.1186/s13023-021-01971-6 |
Ejemplares similares
-
Optimising the diagnosis and referral of achondroplasia in Europe: European Achondroplasia Forum best practice recommendations
por: Cormier-Daire, Valerie, et al.
Publicado: (2022) -
European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis
por: Irving, Melita, et al.
Publicado: (2023) -
Optimising care and follow-up of adults with achondroplasia
por: Fredwall, Svein, et al.
Publicado: (2022) -
Real-world evidence in achondroplasia: considerations for a standardized data set
por: Alanay, Yasemin, et al.
Publicado: (2023) -
Literature review and expert opinion on the impact of achondroplasia on medical complications and health-related quality of life and expectations for long-term impact of vosoritide: a modified Delphi study
por: Savarirayan, Ravi, et al.
Publicado: (2022)